-
Study demonstrates viability of biologics for severe asthma, COPD exacerbations in eosinophilic inflammation
While larger studies are needed, Dharani K. Narendra, MD, FCCP, said the findings from the ABRA trial could be a game changer and reduce the need for glucocorticoids for some patients.
Recent News
-
Updates in ninth edition of TNM classification criteria allow for more precise lung cancer staging
Hisao Asamura, MD, said the changes are critical to clinical decision-making in the evolving thoracic oncology treatment landscape.
-
Artificial intelligence in lung cancer management
As artificial intelligence continues to integrate into clinical practice, the future of lung cancer management is shifting toward precision-driven, data-informed strategies and risk prediction models.
-
CHEST announces critical care education and certification exam for NPs, PAs
CHEST announced the launch of an educational program and formal certification exam for NPs and PAs in critical care.
-
Exploring the evolving landscape in combination therapies for EGFR-mutated advanced NSCLC
Susan Scott, MD, discussed the findings from the MARIPOSA and FLAURA2 trials and the next steps to identify who may benefit from which regimen.
-
FDA proposal would eliminate addicting power of cigarettes, other combustible tobacco products
While the rule could reduce smoking rates, Sven-Eric Jordt, PhD, said clinicians must remember that low-nicotine cigarettes still expose those who smoke to carcinogens.
-
Intersection of American Heart Month and Black History Month offers chance to highlight disparities in care
Marcus St. John, MD, said health system-wide checklists can combat implicit bias and help ensure all patients receive appropriate care.